Stay updated on Frailty-guided Dosing in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Frailty-guided Dosing in Myeloma Clinical Trial page.

Latest updates to the Frailty-guided Dosing in Myeloma Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check14 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.3%
- Check36 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference1.0%
- Check65 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
- Check72 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
Stay in the know with updates to Frailty-guided Dosing in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Frailty-guided Dosing in Myeloma Clinical Trial page.